Journal articles on the topic 'Adjuvant hormone therapy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Adjuvant hormone therapy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Boyages, John, and Ken W. Tiver. "ADJUVANT SYSTEMIC THERAPY IN BREAST CANCER PART 1: ADJUVANT HORMONE THERAPY." ANZ Journal of Surgery 62, no. 5 (May 1992): 354–63. http://dx.doi.org/10.1111/j.1445-2197.1992.tb07203.x.
Full textGupta, S., M. Singh, Amish Vora, G. Babu, M. Walia, V. Nautial, R. Saha, et al. "Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer." South Asian Journal of Cancer 07, no. 02 (April 2018): 142–45. http://dx.doi.org/10.4103/sajc.sajc_122_18.
Full textLatif, Asma, Alexander C. Small, Erin L. Moshier, Kerin B. Adelson, George Raptis, James H. Godbold, William K. Oh, and Matt D. Galsky. "Practice patterns in the use of adjuvant therapy for post-menopausal early-stage breast cancer in the pre- and post-Oncotype DX era." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e21032-e21032. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e21032.
Full textZeng, Erwei, Wei He, Jenny Bergqvist, and Kamila Czence. "Abstract P3-12-04: Extending therapy after 5-year adjuvant hormone therapy in breast cancer patients: A population-based study." Cancer Research 82, no. 4_Supplement (February 15, 2022): P3–12–04—P3–12–04. http://dx.doi.org/10.1158/1538-7445.sabcs21-p3-12-04.
Full textWiltshaw, E. "Adjuvant hormone therapy in ovarian cancer." Biomedicine & Pharmacotherapy 46, no. 4 (January 1992): 176. http://dx.doi.org/10.1016/0753-3322(92)90032-3.
Full textBlomqvist, Carl P., Inkeri Elomaa, and Pentti Rissanen. "Adjuvant Hormone Therapy in Breast Cancer." Annals of Medicine 24, no. 2 (January 1992): 91–96. http://dx.doi.org/10.3109/07853899209148333.
Full textKovalenko, E. I., I. B. Kononenko, A. V. Snegovoi, O. P. Grebennikova, and L. V. Manzyuk. "Adverse effects of adjuvant endocrine therapy." Medical Council, no. 10 (July 19, 2018): 64–69. http://dx.doi.org/10.21518/2079-701x-2018-10-64-69.
Full textLoibl, S., G. von Minckwitz, and M. Kaufmann. "Adjuvant hormone therapy following primary therapy for endometrial cancer." European Journal of Cancer 38 (September 2002): 41–43. http://dx.doi.org/10.1016/s0959-8049(02)00281-2.
Full textSlonimskaya, E. M., A. V. Doroshenko, P. V. Kazantseva, N. A. Tarabanovskaya, and R. Yu Vernadsky. "Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer." Tumors of female reproductive system 14, no. 3 (October 16, 2018): 48–54. http://dx.doi.org/10.17650/1994-4098-2018-14-3-48-54.
Full textCutolo, Maurizio. "SEX HORMONE ADJUVANT THERAPY IN RHEUMATOID ARTHRITIS." Rheumatic Disease Clinics of North America 26, no. 4 (November 2000): 881–95. http://dx.doi.org/10.1016/s0889-857x(05)70174-5.
Full textNeven, P. "ADJUVANT THERAPY FOR HORMONE-DEPENDENT BREAST CANCER." International Journal of Gynecologic Cancer 13, Suppl 1 (March 2003): 116.1–116. http://dx.doi.org/10.1136/ijgc-00009577-200303001-00433.
Full textKimmick, Gretchen, Roger Anderson, Fabian Camacho, Monali Bhosle, Wenke Hwang, and Rajesh Balkrishnan. "Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer." Journal of Clinical Oncology 27, no. 21 (July 20, 2009): 3445–51. http://dx.doi.org/10.1200/jco.2008.19.2419.
Full textMcArthur, H. L., and H. F. Kennecke. "Rationale for Extended Adjuvant Letrozole after Five Years of Tamoxifen in Postmenopausal Oestrogen Receptor–Positive Women with Early-Stage Breast Cancer." Current Oncology 12, no. 3 (September 1, 2005): 78–82. http://dx.doi.org/10.3390/curroncol12030003.
Full textJones, Kellie L., and Aman U. Buzdar. "A review of adjuvant hormonal therapy in breast cancer." Endocrine-Related Cancer 11, no. 3 (September 2004): 391–406. http://dx.doi.org/10.1677/erc.1.00594.
Full textKaisary, A. V., and M. Jarmulowicz. "Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)—Agonist Therapy in Prostate Cancer." UroOncology 3, no. 2 (June 2003): 51–62. http://dx.doi.org/10.1080/1561095031000148772.
Full textDitonno, Pasquale, Michele Battaglia, and Francesco Paolo Selvaggi. "Adjuvant Hormone Therapy after Radical Prostatectomy: Indications and Results." Tumori Journal 83, no. 2 (March 1997): 567–75. http://dx.doi.org/10.1177/030089169708300219.
Full textGiordano, Sharon H., Gabriel N. Hortobagyi, Shu-Wan C. Kau, Richard L. Theriault, and Melissa L. Bondy. "Breast Cancer Treatment Guidelines in Older Women." Journal of Clinical Oncology 23, no. 4 (February 1, 2005): 783–91. http://dx.doi.org/10.1200/jco.2005.04.175.
Full textVan Poppel, Hein. "Neoadjuvant and Adjuvant Hormone Therapy: How and When?" European Urology Supplements 7, no. 13 (December 2008): 747–51. http://dx.doi.org/10.1016/j.eursup.2008.09.001.
Full textBossi, Alberto. "Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?" European Urology Supplements 8, no. 12 (December 2009): 848–51. http://dx.doi.org/10.1016/j.eursup.2009.09.003.
Full textZlotta, Alexandre R., and Claude C. Schulman. "Neoadjuvant and adjuvant hormone therapy for prostate cancer." World Journal of Urology 18, no. 3 (June 16, 2000): 179–82. http://dx.doi.org/10.1007/s003450000119.
Full textKarakas, Yusuf, Serkan Akin, Omer Dizdar, and Sercan Aksoy. "Analysis of the Adjuvant Hormone Therapy Randomized Trial." Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2070. http://dx.doi.org/10.1200/jco.2015.65.4277.
Full textVoutsadakis, Ioannis A. "On Adjuvant Hormone Therapy in Epithelial Ovarian Cancer." Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2070–71. http://dx.doi.org/10.1200/jco.2015.66.3245.
Full textKimmick, G. G., F. Camacho, W. Hwang, and R. T. Anderson. "The relationship between adherence to adjuvant hormonal therapy and survival among low-income, insured women with primary breast cancer." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e11522-e11522. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11522.
Full textThomas, Christian A. "Early-stage breast cancer patients reporting difficulty sleeping, mood issues, or pain are more likely to refuse adjuvant hormone therapy." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12065-e12065. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12065.
Full textLigibel, Jennifer A., and Eric P. Winer. "The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer." Journal of the National Comprehensive Cancer Network 1, no. 2 (April 2003): 215–21. http://dx.doi.org/10.6004/jnccn.2003.0020.
Full textLove, Richard R., Nguyen Ba Duc, D. Craig Allred, Nguyen Cong Binh, Nguyen Van Dinh, Nguyen Ngoc Kha, Tran Van Thuan, et al. "Oophorectomy and Tamoxifen Adjuvant Therapy in Premenopausal Vietnamese and Chinese Women With Operable Breast Cancer." Journal of Clinical Oncology 20, no. 10 (May 15, 2002): 2559–66. http://dx.doi.org/10.1200/jco.2002.08.169.
Full textWiner, Eric P., Clifford Hudis, Harold J. Burstein, Antonio C. Wolff, Kathleen I. Pritchard, James N. Ingle, Rowan T. Chlebowski, et al. "American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004." Journal of Clinical Oncology 23, no. 3 (January 20, 2005): 619–29. http://dx.doi.org/10.1200/jco.2005.09.121.
Full textHe, Wei, Fang Fang, Catherine Varnum, Mikael Eriksson, Per Hall, and Kamila Czene. "Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer." Journal of Clinical Oncology 33, no. 20 (July 10, 2015): 2262–69. http://dx.doi.org/10.1200/jco.2014.59.3673.
Full textLin, C. M., J. Jaswal, T. Vandenberg, A. Tuck, and M. Brackstone. "Weakly hormone receptor– positive breast cancer and use of adjuvant hormonal therapy." Current Oncology 20, no. 6 (September 16, 2013): 612. http://dx.doi.org/10.3747/co.20.1598.
Full textGnant, Michael, Catherine Van Poznak, and Lowell Schnipper. "Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 116–22. http://dx.doi.org/10.1200/edbk_177357.
Full textStrasser-Weippl, Kathrin, and Paul E. Goss. "Adjuvant endocrine therapy options in hormone-dependent breast cancer." European Journal of Cancer Supplements 3, no. 3 (October 2005): 247–54. http://dx.doi.org/10.1016/s1359-6349(05)80281-2.
Full textOvcaricek, Tanja, Iztok Takac, and Erika Matos. "Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer." Radiology and Oncology 53, no. 3 (September 24, 2019): 285–92. http://dx.doi.org/10.2478/raon-2019-0038.
Full textChia, S. K. L. "Clinical application and utility of genomic assays in early-stage breast cancer: key lessons learned to date." Current Oncology 25 (June 14, 2018): 125. http://dx.doi.org/10.3747/co.25.3814.
Full textGreene, Rebecca E., and Vivian Tsang. "Hormonal Therapy for the Treatment of Postmenopausal Breast Cancer Patients." Journal of Pharmacy Practice 21, no. 1 (February 2008): 36–45. http://dx.doi.org/10.1177/0897190008315055.
Full textMori, Ryutaro, and Yasuko Nagao. "The efficacy of second-line hormone therapy for recurrence during adjuvant hormone therapy for breast cancer." Therapeutic Advances in Medical Oncology 6, no. 2 (January 13, 2014): 36–42. http://dx.doi.org/10.1177/1758834013517734.
Full textSvahn, Tiffany H., and Robert W. Carlson. "Modest benefits of adjuvant chemotherapy in hormone receptor-positive breast cancer." Breast Cancer Online 9, no. 7 (May 16, 2006): 1–4. http://dx.doi.org/10.1017/s1470903106004378.
Full textBracken-Clarke, Dara B., Mairi W. Lucas, and Michaela J. Higgins. "Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer." Breast Care 12, no. 3 (2017): 138–44. http://dx.doi.org/10.1159/000477956.
Full textVarnier, Romain, Christophe Sajous, Solène de Talhouet, Colette Smentek, Julien Péron, Benoît You, Thibaut Reverdy, and Gilles Freyer. "Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives." Cancers 13, no. 19 (September 28, 2021): 4840. http://dx.doi.org/10.3390/cancers13194840.
Full textAdami, G., A. Fassio, A. Giollo, G. Orsolini, O. Viapiana, D. Gatti, and M. Rossini. "SAT0456 REAL-LIFE RISK OF FRACTURE AND TREATMENT PREVALENCE IN DRUG-INDUCED OSTEOPOROSIS IN ITALY USING A NEW ALGORITHM." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1185.1–1186. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2565.
Full textSemiglazov, V. F., V. Yu Lifanova, and V. S. Appolonova. "Adjuvant therapy in premenopausal women with hormone-dependent breast cancer." Medical Council, no. 19 (November 11, 2018): 73–75. http://dx.doi.org/10.21518/2079-701x-2018-19-73-75.
Full textShukurov, Farkhad I., and Farida M. Aiupova. "Role of adjuvant hormonal therapy in restoring reproductive function in women after endosurgical treatment of ovarian follicular cysts." Gynecology 23, no. 1 (March 21, 2021): 68–72. http://dx.doi.org/10.26442/20795696.2021.1.200441.
Full textSundar, Santhanam, and Micheal Ocathail. "Adjuvant Hormone Therapy After Prostate Radiation: Is This Data Torture?" Journal of Clinical Oncology 39, no. 20 (July 10, 2021): 2314–15. http://dx.doi.org/10.1200/jco.21.00013.
Full textHedin, T., C. Guo, and A. Nattinger. "Persistence with adjuvant hormone therapy in older breast cancer survivors." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 6032. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6032.
Full textLiu, Feng, Daju Sun, Xueying Zhou, Youpeng Ding, Yanan Ma, Yi Hou, Xiangbo Kong, and Zhixin Wang. "Effect of adjuvant hormone therapy in patients with prostate cancer." Medicine 97, no. 50 (December 2018): e13145. http://dx.doi.org/10.1097/md.0000000000013145.
Full textStrasser-Weippl, Kathrin, Tanja Badovinac-Crnjevic, Lei Fan, and Paul E. Goss. "Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer." Breast 22 (August 2013): S171—S175. http://dx.doi.org/10.1016/j.breast.2013.07.033.
Full textEeles, Rosalind A., James P. Morden, Martin Gore, Janine Mansi, John Glees, Miklos Wenczl, Christopher Williams, et al. "Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer." Obstetrical & Gynecological Survey 71, no. 4 (April 2016): 223–24. http://dx.doi.org/10.1097/ogx.0000000000000308.
Full textKilickap, Saadettin, and Deniz Tural. "Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?" Journal of Clinical Oncology 34, no. 17 (June 10, 2016): 2069. http://dx.doi.org/10.1200/jco.2015.65.3683.
Full textHershman, Dawn L., Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, and Alfred I. Neugut. "Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients." Journal of Clinical Oncology 28, no. 27 (September 20, 2010): 4120–28. http://dx.doi.org/10.1200/jco.2009.25.9655.
Full textMontemurro, Filippo, and Massimo Aglietta. "Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy." Endocrine-Related Cancer 16, no. 4 (December 2009): 1091–102. http://dx.doi.org/10.1677/erc-09-0033.
Full textAngelopoulos, N., V. Barbounis, S. Livadas, D. Kaltsas, and G. Tolis. "Effects of estrogen deprivation due to breast cancer treatment." Endocrine-Related Cancer 11, no. 3 (September 2004): 523–35. http://dx.doi.org/10.1677/erc.1.00783.
Full text